Developer docs
API playgroundTry for free, no card

Search company profiles

b.value AG

Full company profile

uuid000exc4

Namestring
b.value AG
Legal namestring
b.value AG
Websiteurl
bvalue-ag.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

b.value AG is a private venture capital firm (Aktiengesellschaft) headquartered in Dortmund, Germany, that specializes in early-stage DeepTech investments within the European D-A-CH region. The firm acquires minority stakes in Pre-Seed and Seed-phase startups developing proprietary, protected technologies in two core verticals: biotechnology (precision fermentation, sustainable chemicals, food/feed, life science methods, cell culture, regenerative medicine) and new materials (high-performance coated fibers, bio-based plastics and leather alternatives, advanced sensors, semiconductor interconnection materials). Its stated investment thesis rests on three pillars: talented founders, scalable business models, and disruptive protected technologies. b.value AG invests cooperatively alongside other co-investors to mitigate risk and pool resources, focusing on the D-A-CH region for deal sourcing.

The firm's competitive positioning is built on a team of PhD natural scientists with collectively over 25 years of entrepreneurial experience building and leading biotech and HighTech companies, enabling proprietary "under the hood" technology evaluation that goes beyond typical investment due diligence. The current portfolio of nine companies spans b.fab (CO2-based bioprocesses via artificial photosynthesis), Cellbricks (bioprinting of in-vitro models and implants), Cultimate Foods (cultivated fat ingredient), FibreCoat (high-performance coated fibers for composites), FluIDect (real-time microorganism analysis), Nano-Join (semiconductor sintering pasts), PL BioScience (human platelet lysate for cell culture), Revoltech (plant-based leather alternatives), and traceless (bio-based plastic alternatives). Several portfolio companies hold filed or granted patents underpinning their core technologies. The firm is led by a two-person Vorstand (Dr. Georg Lentzen and Peter Kallien), supported by senior investment managers and an Aufsichtsrat providing strategic oversight.

Revenue mechanics are not publicly disclosed; as a private investment firm, b.value AG generates returns through equity appreciation, capital gains, and carried interest from portfolio exits rather than product sales or licensing. The firm operates from a single office at the Biomedizin Zentrum (BMZ) in Dortmund and maintains a small 1–10 employee headcount, consistent with a focused, thesis-driven early-stage investment operation rather than a scaled fund manager.

Short descriptiontext

b.value AG is a Dortmund-based DeepTech venture capital firm that acquires minority stakes in Pre-Seed and Seed-phase biotechnology and new materials startups across the D-A-CH region, combining PhD-level scientific due diligence with co-investor partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDortmund, Germany
HQ citystring
Dortmund
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, deep tech startups, biotechnology investments, seed stage funding, new materials startups
Industry1 code
PRIMARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms
NAICS code2 codes
  • Other Financial Vehicles52599
  • Other Financial Vehicles525990
SIC code1 code
  • Miscellaneous Business Credit Institution6159
Product category
DeepTech Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Capital gains and equity returns
TypeLicensing Royalties
Description

As a DeepTech investment firm, b.value AG generates returns through equity appreciation, capital gains, and carried interest from successful exits of portfolio companies. The firm takes minority stakes in Pre-Seed and Seed-phase startups and supports them financially and strategically until exit.

bvalue.de
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

b.value AG is a venture capital firm that acquires minority equity stakes in Pre-Seed and Seed-stage DeepTech startups within the European D-A-CH region (Germany, Austria, Switzerland). The firm invests cooperatively alongside other co-investors in biotechnology (precision fermentation, sustainable chemicals, Food/Feed, LifeScience methods) and new materials startups, providing both financial capital and strategic support including access to a network of industry experts, scientists, investors, and political decision-makers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Portfolio companies have achieved significant milestones including Series A (€7.8M for PL BioScience), Series B (€20M for FibreCoat), EIC Accelerator funding (€2.5M for FluIDect), and international recognition including Prism Award 2025
Product overview1 text field

b.value AG is a venture capital firm (not a product company) offering investment services in DeepTech startups. The company acquires minority stakes in early-stage biotechnology companies (including precision fermentation, sustainable chemicals, food/feed, and LifeScience methods) and new materials startups. The investment approach focuses on talented founders, scalable business models, and disruptive protected technologies. b.value AG provides strategic guidance, access to an extensive network of industry experts, scientists, investors, and policymakers, and co-invests alongside other investors in the D-A-CH region.

Product and service1 record
1b.value AG Investment Services
CategoryInvestment Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-05-08
Description

PL BioScience (a b.value portfolio company) partnered with the Korean biotech company DewCell Biotherapeutics to develop the world's first artificial human platelet lysate (HPL). DewCell is the first company to produce artificial blood platelets from stem cells in a reactor. Under the collaboration, the product is manufactured in Germany using raw material from DewCell, offering a scalable, safe, and animal-free alternative to fetal bovine serum (FBS) and conventional HPL.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-08-01
Description

b.fab GmbH (a b.value portfolio company) was selected by Hatch Blue for the CREST Accelerator program. Over 4 months, the b.fab team participates in an intensive program across some of the world's most dynamic aquaculture centers in Hawaii, Norway, and Singapore/Vietnam, learning about the industry's challenges and connecting with renowned aquaculture experts.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-18
Description

traceless materials (a b.value portfolio company) entered a strategic partnership with Mondi, a globally leading packaging and paper manufacturer with 22,000 employees across more than 30 countries, to drive large-scale application of traceless® — a novel natural plastic alternative — across the paper industry. Mondi generated €7.3 billion in revenue in 2023. The partnership aims to reduce dependence on fossil fuels and decrease unnecessary plastic waste while ensuring recyclability in existing paper recycling cycles.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Early-stage German tech VC investing across D-A-CH in software and technology-enabled businesses. Already a co-investor alongside b.value AG in portfolio companies (e.g., SenseUP), making it a direct comparable in D-A-CH early-stage tech investing with similar deal sizes and structure.

TypeBroad incumbent
Description

European venture capital firm with deep-tech and life-sciences investment focus across Germany and broader Europe. Comparable in D-A-CH geographic orientation and technology focus, but historically invested at later stages than b.value's Pre-Seed/Seed specialty.

TypeBroad incumbent
Description

Major European life sciences VC firm with multi-stage investments in biotech/healthcare. Comparable in life-sciences focus and European orientation, but operates at much larger scale (growth and later stages) with broader sector mandate than b.value's early-stage focus.

TypeDirect peer
Description

One of Germany's largest Seed-stage DeepTech investors, with a heavy focus on biotech, chemicals, and advanced materials. Directly comparable to b.value AG in stage focus (Pre-Seed/Seed), sector focus (industrial biotech, materials), and D-A-CH geography, but with substantially more capital under management.

TypeDirect peer
Description

Munich-based VC manager focused on German/Austrian life sciences and DeepTech early-stage investments. Closely comparable to b.value AG in life sciences specialization, minority-stake Seed/early-stage strategy, and D-A-CH regional focus.

TypeDirect peer
Description

Dutch early-stage accelerator and VC with a focus on agritech, energy, and emerging technologies. Active co-investor in b.value portfolio companies (SenseUP) and operates with comparable early-stage, sustainability-focused investment thesis across Europe.

TypeRegional player
Description

German state-backed bank providing venture capital financing in North Rhine-Westphalia, including Dortmund (where b.value is based). Comparable in providing early-stage capital to D-A-CH startups, particularly in NRW, but operates as a public-sector investor rather than independent DeepTech specialist.

TypeDirect peer
Description

Munich-based early-stage VC focused on technology-driven impact investments, particularly in industrial tech and sustainability. Directly comparable as a D-A-CH early-stage investor with biotech/tech thesis, and has co-invested with b.value AG in PL BioScience.

TypeDirect peer
Description

German regional VC fund manager investing Seed-to-growth in technology and life sciences across Bavaria and D-A-CH. Comparable early-stage DeepTech/biotech focus and minority-stake approach, though with broader sector mandate and larger fund vehicles.

TypeRegional player
Description

German regional development bank providing venture capital to Lower Saxony startups, comparable in regional German public-sector VC mandate and early-stage ticket sizes, though with broader sector mandate than b.value's biotech/materials specialization.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment13 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

b.value AG

DeepTech Venture Capitalbvalue-ag.com

b.value AG is a Dortmund-based DeepTech venture capital firm that acquires minority stakes in Pre-Seed and Seed-phase biotechnology and new materials startups across the D-A-CH region, combining PhD-level scientific due diligence with co-investor partnerships.

What b.value AG does

b.value AG is a private venture capital firm (Aktiengesellschaft) headquartered in Dortmund, Germany, that specializes in early-stage DeepTech investments within the European D-A-CH region. The firm acquires minority stakes in Pre-Seed and Seed-phase startups developing proprietary, protected technologies in two core verticals: biotechnology (precision fermentation, sustainable chemicals, food/feed, life science methods, cell culture, regenerative medicine) and new materials (high-performance coated fibers, bio-based plastics and leather alternatives, advanced sensors, semiconductor interconnection materials). Its stated investment thesis rests on three pillars: talented founders, scalable business models, and disruptive protected technologies. b.value AG invests cooperatively alongside other co-investors to mitigate risk and pool resources, focusing on the D-A-CH region for deal sourcing.

The firm's competitive positioning is built on a team of PhD natural scientists with collectively over 25 years of entrepreneurial experience building and leading biotech and HighTech companies, enabling proprietary "under the hood" technology evaluation that goes beyond typical investment due diligence. The current portfolio of nine companies spans b.fab (CO2-based bioprocesses via artificial photosynthesis), Cellbricks (bioprinting of in-vitro models and implants), Cultimate Foods (cultivated fat ingredient), FibreCoat (high-performance coated fibers for composites), FluIDect (real-time microorganism analysis), Nano-Join (semiconductor sintering pasts), PL BioScience (human platelet lysate for cell culture), Revoltech (plant-based leather alternatives), and traceless (bio-based plastic alternatives). Several portfolio companies hold filed or granted patents underpinning their core technologies. The firm is led by a two-person Vorstand (Dr. Georg Lentzen and Peter Kallien), supported by senior investment managers and an Aufsichtsrat providing strategic oversight.

Revenue mechanics are not publicly disclosed; as a private investment firm, b.value AG generates returns through equity appreciation, capital gains, and carried interest from portfolio exits rather than product sales or licensing. The firm operates from a single office at the Biomedizin Zentrum (BMZ) in Dortmund and maintains a small 1–10 employee headcount, consistent with a focused, thesis-driven early-stage investment operation rather than a scaled fund manager.

b.value AG firmographics

Firmographics
Name
b.value AG
Legal name
b.value AG
Website
https://bvalue-ag.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
b.value AG is a Dortmund-based DeepTech venture capital firm that acquires minority stakes in Pre-Seed and Seed-phase biotechnology and new materials startups across the D-A-CH region, combining PhD-level scientific due diligence with co-investor partnerships.
Ownership category
akta.pro rank

b.value AG industry classification

Industry
Product category
DeepTech Venture Capital
NAICS
Other Financial Vehicles (52599), Other Financial Vehicles (525990)
SIC
Miscellaneous Business Credit Institution (6159)
akta.pro industry
PRIMARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms

Keywords

  • Venture capital investing
  • Deep tech startups
  • Biotechnology investments
  • Seed stage funding
  • New materials startups

Where b.value AG is headquartered

Location

Headquarters

HQ city
Dortmund
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

b.value AG business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Capital gains and equity returns: As a DeepTech investment firm, b.value AG generates returns through equity appreciation, capital gains, and carried interest from successful exits of portfolio companies. The firm takes minority stakes in Pre-Seed and Seed-phase startups and supports them financially and strategically until exit.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

b.value AG product offering

Product offering

Core offering

b.value AG is a venture capital firm that acquires minority equity stakes in Pre-Seed and Seed-stage DeepTech startups within the European D-A-CH region (Germany, Austria, Switzerland). The firm invests cooperatively alongside other co-investors in biotechnology (precision fermentation, sustainable chemicals, Food/Feed, LifeScience methods) and new materials startups, providing both financial capital and strategic support including access to a network of industry experts, scientists, investors, and political decision-makers.

Product overview

b.value AG is a venture capital firm (not a product company) offering investment services in DeepTech startups. The company acquires minority stakes in early-stage biotechnology companies (including precision fermentation, sustainable chemicals, food/feed, and LifeScience methods) and new materials startups. The investment approach focuses on talented founders, scalable business models, and disruptive protected technologies. b.value AG provides strategic guidance, access to an extensive network of industry experts, scientists, investors, and policymakers, and co-invests alongside other investors in the D-A-CH region.

Differentiator

Problem solved

Functional benefit

Products and services

  • b.value AG Investment Services

Quantifiable outcome

  • Portfolio companies have achieved significant milestones including Series A (€7.8M for PL BioScience), Series B (€20M for FibreCoat), EIC Accelerator funding (€2.5M for FluIDect), and international recognition including Prism Award 2025

Companies that use b.value AG

Customer profile

Segments2 records

Ideal customer profiles1 record

b.value AG technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

b.value AG partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • DewCell BiotherapeuticscoreTechnology or Integration · 8 May 2025PL BioScience (a b.value portfolio company) partnered with the Korean biotech company DewCell Biotherapeutics to develop the world's first artificial human platelet lysate (HPL). DewCell is the first company to produce artificial blood platelets from stem cells in a reactor. Under the collaboration, the product is manufactured in Germany using raw material from DewCell, offering a scalable, safe, and animal-free alternative to fetal bovine serum (FBS) and conventional HPL.
  • Hatch Blue CREST AcceleratorminorGTM or Marketing Partner · 1 August 2024b.fab GmbH (a b.value portfolio company) was selected by Hatch Blue for the CREST Accelerator program. Over 4 months, the b.fab team participates in an intensive program across some of the world's most dynamic aquaculture centers in Hawaii, Norway, and Singapore/Vietnam, learning about the industry's challenges and connecting with renowned aquaculture experts.
  • MondicoreStrategic or Co-development Partner · 18 June 2024traceless materials (a b.value portfolio company) entered a strategic partnership with Mondi, a globally leading packaging and paper manufacturer with 22,000 employees across more than 30 countries, to drive large-scale application of traceless® — a novel natural plastic alternative — across the paper industry. Mondi generated €7.3 billion in revenue in 2023. The partnership aims to reduce dependence on fossil fuels and decrease unnecessary plastic waste while ensuring recyclability in existing paper recycling cycles.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

b.value AG competitors and assessment

Company assessment

Direct peers

  • Capnamic Ventures: Early-stage German tech VC investing across D-A-CH in software and technology-enabled businesses. Already a co-investor alongside b.value AG in portfolio companies (e.g., SenseUP), making it a direct comparable in D-A-CH early-stage tech investing with similar deal sizes and structure.
  • High-Tech Gründerfonds (HTGF): One of Germany's largest Seed-stage DeepTech investors, with a heavy focus on biotech, chemicals, and advanced materials. Directly comparable to b.value AG in stage focus (Pre-Seed/Seed), sector focus (industrial biotech, materials), and D-A-CH geography, but with substantially more capital under management.
  • MIG Capital: Munich-based VC manager focused on German/Austrian life sciences and DeepTech early-stage investments. Closely comparable to b.value AG in life sciences specialization, minority-stake Seed/early-stage strategy, and D-A-CH regional focus.
  • Rockstart: Dutch early-stage accelerator and VC with a focus on agritech, energy, and emerging technologies. Active co-investor in b.value portfolio companies (SenseUP) and operates with comparable early-stage, sustainability-focused investment thesis across Europe.
  • Better Ventures: Munich-based early-stage VC focused on technology-driven impact investments, particularly in industrial tech and sustainability. Directly comparable as a D-A-CH early-stage investor with biotech/tech thesis, and has co-invested with b.value AG in PL BioScience.
  • Bayern Kapital: German regional VC fund manager investing Seed-to-growth in technology and life sciences across Bavaria and D-A-CH. Comparable early-stage DeepTech/biotech focus and minority-stake approach, though with broader sector mandate and larger fund vehicles.

Broad incumbents

  • Wellington Partners: European venture capital firm with deep-tech and life-sciences investment focus across Germany and broader Europe. Comparable in D-A-CH geographic orientation and technology focus, but historically invested at later stages than b.value's Pre-Seed/Seed specialty.
  • Forbion: Major European life sciences VC firm with multi-stage investments in biotech/healthcare. Comparable in life-sciences focus and European orientation, but operates at much larger scale (growth and later stages) with broader sector mandate than b.value's early-stage focus.

Regional players

  • NRW.BANK Venture Center: German state-backed bank providing venture capital financing in North Rhine-Westphalia, including Dortmund (where b.value is based). Comparable in providing early-stage capital to D-A-CH startups, particularly in NRW, but operates as a public-sector investor rather than independent DeepTech specialist.
  • Investitions- und Förderbank Niedersachsen (NBank): German regional development bank providing venture capital to Lower Saxony startups, comparable in regional German public-sector VC mandate and early-stage ticket sizes, though with broader sector mandate than b.value's biotech/materials specialization.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

b.value AG social profiles

Digital presence

b.value AG financial estimates

Financial estimate

Revenue estimate

Valuation estimate

b.value AG leadership team

Management profile

Number of profiles

Profiles5 records

b.value AG funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

b.value AG M&A and investment

M&A and investment

M&A

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about b.value AG

What does b.value AG do?

b.value AG is a venture capital firm that acquires minority equity stakes in Pre-Seed and Seed-stage DeepTech startups within the European D-A-CH region (Germany, Austria, Switzerland). The firm invests cooperatively alongside other co-investors in biotechnology (precision fermentation, sustainable chemicals, Food/Feed, LifeScience methods) and new materials startups, providing both financial capital and strategic support including access to a network of industry experts, scientists, investors, and political decision-makers.

Is b.value AG a public or private company?

b.value AG is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was b.value AG founded?

b.value AG was founded in 2016. It employs 1 to 10 people.

Where is b.value AG based?

b.value AG is headquartered in Dortmund, Germany, in the Europe region.

How does b.value AG make money?

One revenue line is on record: capital gains and equity returns.

Who are b.value AG's main competitors?

Direct peers on record are Capnamic Ventures, High-Tech Gründerfonds (HTGF), MIG Capital, Rockstart, Better Ventures and Bayern Kapital. Broad incumbents are Wellington Partners and Forbion. Regional players are NRW.BANK Venture Center and Investitions- und Förderbank Niedersachsen (NBank).

Does b.value AG have an API?

No public API is recorded for b.value AG.

What industry is b.value AG in?

b.value AG's product category is DeepTech Venture Capital. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms. Its NAICS code is 52599 and its SIC code is 6159.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals